Galectin-3 and Myocardial Fibrosis By Cardiac Magnetic Resonance in Thalassaemia Major

被引：3

作者：

Ricchi, Paolo ^{[1
]}

Meloni, Antonella ^{[2
]}

Di Matola, Tiziana ^{[3
]}

Spasiano, Anna ^{[4
]}

Filosa, Aldo ^{[4
]}

Costantini, Silvia ^{[4
]}

Atripaldi, Luigi ^{[5
]}

Esposito, Salvatore ^{[3
]}

Cinque, Patrizia ^{[4
]}

De Franceschi, Lucia ^{[6
]}

Pepe, Alessia ^{[2
]}

机构：

[1] Azienda Osped Rilievo Nazl, Unita Operat Semplice Dipartimentale Malattie Rar, Naples, Italy

[2] Fdn G Monasterio CNR Reg Toscana, CMR Unit, Pisa, Italy

[3] AORN Osped Colli Napoli, UOSD Patol Clin, Naples, Italy

[4] Azienda Osped Rilievo Nazl A Cardarelli, Unita Operat Semplice Dipartimentale Malattie Rar, Naples, Italy

[5] AORN Monaldi Cotugno CTO, UOC Clin Pathol, Naples, Italy

[6] Univ Verona, Verona, Italy

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.4832.4832

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Galectin-3 in cardiac remodeling and heart failure
De Boer R.A.
Yu L.
Van Veldhuisen D.J.
Current Heart Failure Reports, 2010, 7 (1) : 1 - 8
[42] Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy
Choi, Hong-Mi
Kim, Kyung-Hee
Lee, Joo Myung
Yoon, Yeonyee E.
Lee, Seung-Pyo
Park, Eun-Ah
Lee, Whal
Kim, Yong-Jin
Cho, Goo-Yeong
Sohn, Dae-Won
Kim, Hyung-Kwan
HEART, 2015, 101 (11) : 870 - 876
[43] A Novel Measure of Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance
Nazarian, Saman
Bluemke, David A.
Wagner, Kathryn R.
Caffo, Brian S.
Shehata, Monda
Edwards, David
Butcher, Barbara
Calkins, Hugh
Berger, Ronald D.
Halperin, Henry R.
Tomaselli, Gordon F.
CIRCULATION, 2008, 118 (18) : S692 - S692
[44] Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Yu, Lili
Ruifrok, Willem P. T.
Meissner, Maxi
Bos, Eelke M.
van Goor, Harry
Sanjabi, Bahram
van der Harst, Pim
Pitt, Bertram
Goldstein, Irwin J.
Koerts, Jasper A.
van Veldhuisen, Dirk J.
Bank, Ruud A.
van Gilst, Wiek H.
Sillje, Herman H. W.
de Boer, Rudolf A.
CIRCULATION-HEART FAILURE, 2013, 6 (01) : 107 - +
[45] Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling
Sharma, Umesh C.
Mosleh, Wassim
Chaudhari, Milind R.
Katkar, Rujuta
Weil, Brian
Evelo, Chris
Cimato, Thomas R.
Pokharel, Saraswati
Blankesteijn, W. Matthijs
Suzuki, Gen
HEART LUNG AND CIRCULATION, 2017, 26 (07): : 736 - 745
[46] Plasma galectin-3, a marker of myocardial fibrosis, is poorly related to the volume of myocardial scar in patients with heart failure
Sherwi, N.
Lukaschuk, E.
Zhang, J.
Nicholls, R.
Pellicori, P.
Torabi, A.
Yassin, A.
Clark, A. L.
Wong, K. Y. K.
Cleland, J. G. F.
EUROPEAN HEART JOURNAL, 2014, 35 : 1012 - 1012
[47] The fibrosis marker galectin-3 and outcome in the general population
de Boer, R. A.
van Veldhuisen, D. J.
Gansevoort, R. T.
Kobold, A. C. Muller
van Gilst, W. H.
Hillege, H. L.
Bakker, S. J. L.
van der Harst, P.
JOURNAL OF INTERNAL MEDICINE, 2012, 272 (01) : 55 - 64
[48] Prognostic value of galectin-3, a novel marker of fibrosis
Dirk J. Lok
Pieta W. Bruggink
Peter van der Meer
Clinical Research in Cardiology, 2010, 99 : 529 - 529
[49] Reduction of Tendon Fibrosis Using Galectin-3 Inhibitors
Spielman, Amanda F.
Griffin, Michelle F.
Titan, Ashley L.
Guardino, Nicholas
Cotterell, Asha C.
Akras, Deena
Wan, Derrick C.
Longaker, Michael T.
PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 154 (01) : 113 - 121
[50] Galectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, NC
Mackinnon, AC
Farnworth, SL
Poirier, F
Russo, FP
Iredale, JP
Haslett, C
Simpson, KJ
Sethi, T
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) : 5060 - 5065

← 1 2 3 4 5 →